LuisT.CamposMD

Oncology • Houston, TX

Physician

Join to view full profile

Dr. Campos is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Campos' full profile

Already have an account?

Office
925 Gessner
Suite 600
Houston, TX 77024
Phone+1 713-827-9525

Fax+1 713-827-1380

Education & Training

University of Texas Health Science Center at HoustonFellowship, Medical Oncology, 1973 - 1975
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1972 - 1975
Graduate HospitalResidency, Internal Medicine, 1971 - 1972
Beaumont Hospital, Grosse PointeInternship, Transitional Year, 1970 - 1971
Cayetano Heredia UniversityClass of 1969

Certifications & Licensure

TX State Medical License 1975 - 2026
WA State Medical License 1973 - 2006
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Top MD Consumers Checkbook

Clinical Trials

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor Start of enrollment: 2012 Aug 07
Completed
Phase 3

Publications & Presentations

PubMed

81 citations
Randomized Placebo-Controlled Phase II Trial of Perifosine Plus Capecitabine As Second- or Third-Line Therapy in Patients With Metastatic Colorectal Cancer
Johanna C. Bendell, John Nemunaitis, Sasha Vukelja, Christopher Hagenstad, Luis T. Campos
Journal of Clinical Oncology. 2011-11-20
1127 citations
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063):...
Naiyer A. Rizvi, Julien Mazieres, David Planchard, Thomas E. Stinchcombe, Grace K. Dy
The Lancet. Oncology. 2015-03-01
4 citations
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer.
Luis T. Campos
Cancer. 1993-02-01

Professional Memberships

American Society of Clinical Oncology - ASCO
Member